Therefore, it was supported that C35 is capable of selectively binding to EphB4-expressing angiogenic blood vessels and EphB4-expressing tumor cells, rendering it an appealing bioimaging agent for both PET/CT and optical imaging of glioblastoma. The gene discussed is EPHB4; the disease is glioblastoma.